ArticleMedicine2020

XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma: Evidence based on 4306 patients and 4779 controls.

Feng Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.